Disclosure (pre-set forms); an aid to the disclosure process helps both the inventor and the TDO better characterize the invention and its potential field of use/utility. The technology or product is clearly described in terms of its function, stage of development, hindrances to further development, advantages/disadvantages compared to other similar products, etc. In addition, this disclosure serves as an assignment of rights from the inventor to BC Cancer. This disclosure is presented to the BC Cancer Patent Committee, a select group of senior scientists at the BC Cancer with experience in IP protection and commercialization, for evaluation. The Patent Committee recommends a course of action which may include the following options: not to pursue; further scientific or clinical development; or the protection of the invention and start of the commercialization process.
The completed invention disclosure form should be forwarded to Ron Lauener, Technology Manager, firstname.lastname@example.org or Patrick Rebstein, Senior Manager, Intellectual Property, email@example.com, in electronic format as well as an original copy signed by the inventor and the appropriate department head.
Please contact Ron Lauener or Patrick Rebstein and they will provide you with the template.
A Non-Disclosure Agreement (NDA), also known as a Confidentiality Agreement, is a contract between two parties requiring the recipient of confidential information to hold that information confidential. In the event of public disclosure, the recipient could be sued for breach of contract.
A NDA should be signed whenever confidential information is released. An agreement should always be signed by a new employee, anyone visiting labs (detailed visits) or anyone who receives business plans or other confidential documents. NOTE: Always mark everything CONFIDENTIAL in order for it to be restricted under the non-disclosure agreement.
Please contact us and we will prepare a Non-Disclosure Agreement.
A Material Transfer Agreement (MTA) is a contract that governs the transfer of one or more materials from the owner to or authorized licensee to an institution for research purposes. Materials may include cultures, cell lines, plasmids, nucleotides, proteins, bacteria, transgenic animals, pharmaceuticals and other chemicals. Generally the terms and conditions in a MTA include:
Definition of the material
Restrictions on recipient's use of the material
Provider's rights to inventions and research results
Recipient's obligation of confidentiality
Provider's access to reports and publications
Warranty disclaimer and indemnification
Source: Brian Leslie, AUTM Educational Series: Material Transfer Agreements, 1998.
Please contact us and we will prepare a Material Transfer Agreement.
Employees of BC Cancer should note that the PHSA Intellectual Property Policy applies to any technology transfer activities conducted at all BC Cancer sites. If you have any questions, please contact TDO.